Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Commerce Committee expected to mark up FDA reform legislation by mid-July.

This article was originally published in The Gray Sheet

Executive Summary

HOUSE COMMERCE FDA REFORM LEGISLATION EXPECTED TO BE MARKED UP BY MID-JULY, with the goal of securing passage by the House and completing conference negotiations with the Senate before Congress' August recess begins on Aug. 2. Sen. James Jeffords' (R-Vt.) FDA reform legislation was reported out of the Labor and Human Resources Committee June 18 ("The Gray Sheet" June 23, p. 8).

Latest Headlines
See All
UsernamePublicRestriction

Register

MT008306

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel